These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17473488)

  • 1. Myasthenia gravis and diabetes mellitus: a 35-year retrospective study.
    Wakata N; Nemoto H; Konno S; Nakazora H; Nomoto N; Sugimoto H; Kurihara T
    Intern Med; 2007; 46(9):557-9. PubMed ID: 17473488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of perioperative high-dose prednisolone therapy during thymectomy in myasthenia gravis patients.
    Yamada Y; Yoshida S; Suzuki H; Tagawa T; Iwata T; Mizobuchi T; Kawaguchi N; Yoshino I
    J Cardiothorac Surg; 2013 Dec; 8():226. PubMed ID: 24321421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.
    Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y
    Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
    Palace J; Newsom-Davis J; Lecky B
    Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis.
    Uzawa A; Kawaguchi N; Kanai T; Himuro K; Oda F; Yoshida S; Yoshino I; Kuwabara S
    J Neurol; 2015; 262(4):1019-23. PubMed ID: 25683765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of ocular symptoms after remission of myasthenia gravis--a comparison of relapsed and complete remission cases.
    Wakata N; Iguchi H; Sugimoto H; Nomoto N; Kurihara T
    Clin Neurol Neurosurg; 2003 Apr; 105(2):75-7. PubMed ID: 12691794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
    Wakata N; Nemoto H; Sugimoto H; Nomoto N; Konno S; Hayashi N; Araki Y; Nakazato A
    Clin Neurol Neurosurg; 2004 Mar; 106(2):139-41. PubMed ID: 15003307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-acetylcholine receptor antibodies: effect of immunosuppressive drug therapy in patients with myasthenia gravis].
    Sidnev DV; Sanadze AG; Dedaev SI; Karganov MIu; Alchinova IB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):37-40. PubMed ID: 21183922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Trial of Thymectomy in Myasthenia Gravis.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of myasthenia gravis accompanied by large thymoma and anti-GAD antibody].
    Kitae S; Kawakami H; Matsuoka N; Etoh R; Nakamura S
    Rinsho Shinkeigaku; 2001 Nov; 41(11):818-21. PubMed ID: 12080617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
    Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
    Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indication of thymectomy and immunotherapies on myasthenia gravis].
    Murai H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):875-6. PubMed ID: 18210823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative steroid therapy stabilizes postoperative respiratory condition in myasthenia gravis.
    Fujii Y
    Gen Thorac Cardiovasc Surg; 2008 Mar; 56(3):95-6. PubMed ID: 18340506
    [No Abstract]   [Full Text] [Related]  

  • 15. Appearance of thymoma 5 years after thymectomy for nonthymomatous myasthenia gravis.
    Zouvelou V; Velonakis G; Rontogianni D; Zisis C
    J Clin Neuromuscul Dis; 2014 Sep; 16(1):42-3. PubMed ID: 25137516
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of myasthenia gravis, who developed minimal change nephrotic syndrome during immunosuppressive therapy after thymectomy].
    Takahashi K; Inoue Y; Matsuda O; Takemura T; Yoshimura A
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):394-8. PubMed ID: 10998921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case with myasthenia gravis (MG) emerging after splenectomy for idiopathic thrombocytopenic purpura (ITP): possible effects of thymectomy on autoantibodies.
    Matsuno S; Tamaoka A; Yoshizawa K; Watanabe M; Shoji S
    J Med; 2000; 31(5-6):327-32. PubMed ID: 11508326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan.
    Imai T; Utsugisawa K; Murai H; Tsuda E; Nagane Y; Suzuki Y; Minami N; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Akaishi T; Aoki M
    J Neurol Neurosurg Psychiatry; 2018 May; 89(5):513-517. PubMed ID: 29175893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients.
    Nakahara K; Nakane S; Nakajima M; Yamashita S; Mori T; Ando Y
    J Neuroimmunol; 2017 Apr; 305():182-185. PubMed ID: 28100409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.